Key Points:
- Public comments on IQOS MRTP renewals are due by December 8, 2025, 11:59 p.m. ET.
- Applications include: FDA-2021-N-0408 (IQOS 3.0) and FDA-2017-D-3001 (IQOS 2.4 and Marlboro HeatSticks).
- Redacted application materials are available on the FDA website.
- FDA will consider public input and recommendations from TPSAC before final determination.
- TPSAC held its meeting on October 7, 2025; meeting materials are now public.
2Firsts, Nov. 7, 2025 — The U.S. Food and Drug Administration (FDA) announced the closing date for the public comment period on modified risk tobacco product (MRTP) renewal applications submitted by Philip Morris Products S.A. for several IQOS heated tobacco products.
Public comments on these applications must be submitted by 11:59 p.m. Eastern Time on December 8, 2025, to the appropriate docket to ensure they are considered by FDA.
The relevant docket numbers are:
- FDA-2021-N-0408: IQOS 3.0 System Holder and Charger;
- FDA-2017-D-3001: IQOS 2.4 System Holder and Charger, and Marlboro HeatSticks products.
According to FDA, the application materials—redacted in accordance with applicable laws—are available on the agency’s website. Before making a final determination on any MRTP application, FDA considers all relevant information available to the agency, including public comments and recommendations from the Tobacco Products Scientific Advisory Committee (TPSAC).
FDA held a TPSAC meeting on October 7, 2025, to discuss these renewal applications. The public was able to attend virtually and present comments to the committee. All materials from the meeting are posted on FDA’s website.
For ongoing updates on MRTP applications under scientific review, FDA encourages stakeholders to subscribe to its email alert service.
Image Source: FDA
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
